Neonatal Jaundice: Diagnosis and Management

Neonatal jaundice, characterized by yellowing of the skin and sclera due to elevated bilirubin levels, is a common condition affecting newborns. Early diagnosis and effective management are crucial to prevent complications. Diagnostic methods include assessing bilirubin levels through blood tests and evaluating clinical signs such as skin coloration. Management strategies often begin with phototherapy, exposing the baby to blue light to break down excess bilirubin in the skin. In severe cases, exchange transfusion may be necessary to rapidly lower bilirubin levels. Monitoring hydration, feeding patterns, and stooling frequency are also essential during treatment. Parents are educated about signs of worsening jaundice and advised on when to seek medical attention promptly. Timely intervention ensures that neonates with jaundice receive appropriate care, minimizing the risk of complications such as kernicterus, a rare but serious neurological condition associated with high bilirubin levels. Healthcare providers play a crucial role in educating families and implementing effective management protocols to safeguard newborn health.

    Related Conference of Neonatal Jaundice: Diagnosis and Management

    June 22-23, 2026

    35th World Congress on Clinical Pediatrics

    Barcelona, Spain
    June 29-30, 2026

    6th Global Summit on Pediatric Nursing

    Barcelona, Spain
    July 27-28, 2026

    3rd World Pediatric Conference

    London, UK
    August 18-19, 2026

    8th World Pediatric Infectious Disease Congress

    Paris, France
    September 07-08, 2026

    24rd World Congress on Clinical Pediatrics

    Toronto, Canada
    September 14-15, 2026

    26th Annual Congress on Pediatrics & Neonatology

    Rome, Italy
    November 19-20, 2026

    37th European Pediatrics Conference

    Dubai, UAE

    Neonatal Jaundice: Diagnosis and Management Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in